Mulya.ai
Ticker
MCK
Scenario
Key Inputs
Revenue est.?Analyst
OP margin est.?Analyst
Reinvestment est.?avg_lt_ttm
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?6.2%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?0.475
Beta (levered) ?0.504
Terminal OM% ?1.3%
Segment conc. ?91% dominant
Terminal growth ?4.1%
Bond rating ?AAA · 0.60%
ROIC option ?Opt 4 · 23.6%
Prob of failure ?0.0%
Pipeline validated · 2026-07-21

MCK · McKesson Corporation

$763.512026-07-21
Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors

Intrinsic Value Range Comparison · Mulya.ai

Bull
$1311
+71.7% vs market
Base · active
$1046
+37.0% vs market
Bear
$710
-7.1% vs market
Mulya.ai vs Analyst IV Comparison?
Bear $710
Market $764
Median $970
Base $1046
Bull $1311
Market Price $764
Mulya.ai Base $1046
Analysts Median $970
Mulya.ai IV range ($710 · $1311)
Analysts Range ($875 · $1085)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2024.Q4$309.0B1.3%16.6%$3.3B−$341MM$2.9B5.5%0.0%−$630MM$24.47
2025.Q3$359.1B16.2%1.2%25.1%$3.3B−$2.6B$653MM6.5%191.2%$4.1B$26.85
2025.Q4$359.1B0.0%1.2%20.1%$3.5B$1.1B$4.6B5.7%317.4%−$1.9B$26.85
2026.Q3$403.4B12.4%1.6%18.6%$5.3B$2.0B$7.3B6.1%1433.1%$2.6B$38.81
2026.Q4$403.4B0.0%1.6%17.8%$5.2B−$2.2B$3.0B5.5%338.0%$514MM$38.8114.7
italics below = DCF projection · 10yr Rev CAGR: 7.7%
2027.Q4$432.9B+7.3%1.6%18.0%$5.6B−$3.5B$2.1B6.5%$2.0B248.7%$4.0B$45.7116.7
2028.Q4$464.0B+7.2%1.7%18.2%$6.4B−$2.2B$4.2B6.7%$3.7B125.5%$6.2B$51.9314.7
2029.Q4$501.6B+8.1%1.8%18.4%$7.3B−$1.8B$5.4B6.9%$4.5B103.0%$8.0B$59.4412.8
2030.Q4$530.6B+5.8%1.9%18.7%$8.4B−$1.1B$7.3B7.1%$5.6B98.2%$9.1B$68.4811.1
2031.Q4$595.9B+12.3%1.9%18.9%$9.4B−$2.0B$7.4B7.3%$5.3B93.0%$11.1B$76.6910.0
Term. Yr+$884.5B4.1%1.3%20.0%$9.4B−$1.6B$7.8B8.6%$84.5B23.6%
Active scenario IV: $1046 (+37.0% vs market)